Literature DB >> 10673772

Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11.

T Li1, D Ball, J Zhao, R M Murray, X Liu, P C Sham, D A Collier.   

Abstract

Family-based linkage disequilibrium mapping using SNP markers is expected to be a major route to the identification of susceptibility alleles for complex diseases. However there are a number of methodological issues yet to be resolved, including the handling of extended haplotype data and analysis of haplotype transmission in sib-pair or family trio samples. In the present study, we have analysed two dinucleotide repeat and six SNP markers at the COMT locus at chromosome 22q11, a region implicated in psychosis, for transmission distortion in 198 Chinese schizophrenic family trios. When individual markers were analysed using the TDT, two showed modest evidence of transmission distortion (186C/T, P = 0.04; Val158Met, P = 0.01). Using haplotypes of paired markers analysed by the program TRANSMIT, the most significant P value was 0.001, for the Met158Val and 900ins/delC polymorphisms in the COMT gene. The global P value for the haplotypes of all six SNP markers tested was 0.004, largely a result of the excess transmission of two extended haplotypes which differed at the marker 408C/G. The exclusion of this marker from the analysis gave a global P value of 0.002 and produced a five marker haplotype system which was significant at P = 0.0006. This haplotype consisted of the alleles -287G:186C:Val158:900insC:ARVCF930C, which may represent a background haplotype for the transmission of a schizophrenia susceptibility allele at chromosome 22q11. Our results support the hypotheses that either COMT is itself a susceptibility gene, or more likely that this region of chromosome 22 contains a susceptibility gene that is in linkage disequilibrium with COMT alleles. Molecular Psychiatry (2000) 5, 77-84.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673772     DOI: 10.1038/sj.mp.4000638

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  30 in total

Review 1.  Recent advances in the genetics of schizophrenia.

Authors:  D M Waterwort; A S Bassett; L M Brzustowicz
Journal:  Cell Mol Life Sci       Date:  2002-02       Impact factor: 9.261

Review 2.  Genetic abnormalities of chromosome 22 and the development of psychosis.

Authors:  Nigel M Williams; Michael J Owen
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

Review 3.  Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.

Authors:  William R Perlman; Cynthia Shannon Weickert; Mayada Akil; Joel E Kleinman
Journal:  J Psychiatry Neurosci       Date:  2004-07       Impact factor: 6.186

Review 4.  Normal genetic variation, cognition, and aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Behav Cogn Neurosci Rev       Date:  2003-12

5.  Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Amanda J Law; Amos Frisch; Jingshan Chen; Omer Zarchi; Elena Michaelovsky; Renee Ren-Patterson; Barbara K Lipska; Miri Carmel; Bhaskar Kolachana; Abraham Weizman; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2013-08-28       Impact factor: 13.382

6.  Biological phenotypes and genetic research on schizophrenia.

Authors:  Daniel R Weinberger
Journal:  World Psychiatry       Date:  2002-02       Impact factor: 49.548

7.  Morphological changes in gray matter volume correlate with catechol-O-methyl transferase gene Val158Met polymorphism in first-episode treatment-naïve patients with schizophrenia.

Authors:  Ming-Li Li; Bo Xiang; Yin-Fei Li; Xun Hu; Qiang Wang; Wan-Jun Guo; Wei Lei; Chao-Hua Huang; Lian-Sheng Zhao; Na Li; Hong-Yan Ren; Hui-Yao Wang; Xiao-Hong Ma; Wei Deng; Tao Li
Journal:  Neurosci Bull       Date:  2015-01-06       Impact factor: 5.203

Review 8.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia.

Authors:  Jubao Duan; Maria Martinez; Alan R Sanders; Cuiping Hou; Naruya Saitou; Takashi Kitano; Bryan J Mowry; Raymond R Crowe; Jeremy M Silverman; Douglas F Levinson; Pablo V Gejman
Journal:  Am J Hum Genet       Date:  2004-08-24       Impact factor: 11.025

10.  The complex global pattern of genetic variation and linkage disequilibrium at catechol-O-methyltransferase.

Authors:  N Mukherjee; K K Kidd; A J Pakstis; W C Speed; H Li; Z Tarnok; C Barta; S L B Kajuna; J R Kidd
Journal:  Mol Psychiatry       Date:  2008-06-24       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.